Plant-based meat
-
DATABASE (852)
-
ARTICLES (622)
Founded in 2017 in Hong Kong, Happiness Capital invests in seed to growth stage companies in the US, Europe, Israel, and China, with a focus on issues affecting global happiness within the areas of citizen trust, food, health, climate change, and reduced inequalities. It hosts its own annual contest, the Super Happiness Challenge , a global open innovation contest to fund individuals and startups with ideas and new products or services that tapped into unmet needs to achieve happiness, with a possible $1m in total investment on offer. The VC currently has 37 startups in its portfolio, around half of which are in foodtech and agtech. Its most recent investments include leading the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions, and co-leading the $29m February 2021 Series A round of Israeli 3D printed alt-meat startup Redefine Meat.
Founded in 2017 in Hong Kong, Happiness Capital invests in seed to growth stage companies in the US, Europe, Israel, and China, with a focus on issues affecting global happiness within the areas of citizen trust, food, health, climate change, and reduced inequalities. It hosts its own annual contest, the Super Happiness Challenge , a global open innovation contest to fund individuals and startups with ideas and new products or services that tapped into unmet needs to achieve happiness, with a possible $1m in total investment on offer. The VC currently has 37 startups in its portfolio, around half of which are in foodtech and agtech. Its most recent investments include leading the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions, and co-leading the $29m February 2021 Series A round of Israeli 3D printed alt-meat startup Redefine Meat.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Co-founder of Meatable
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Rubio Impact Ventures (formerly Social Impact Ventures)
Founded in Amsterdam in 2014, Rubio Impact Ventures was formerly known as Social Impact Ventures. The VC currently invests in sustainability-focused startups that are predominantly based in the Netherlands and north-western Europe. It currently has 27 portfolio companies including fair coffee brand Wakuli and cultured meat pioneer Masa Meat. The “Rubicon crossing” VC has just raised €110m for its second impact fund, Rubio Fund 2, in October 2021.Recent investments include participation in the $43m Series B round of food-sharing app OLIO in September 2021 and the €3.6m seed round in July 2021 for Portuguese Arborea that uses micro-organisms in biotech for foodtech applications.
Founded in Amsterdam in 2014, Rubio Impact Ventures was formerly known as Social Impact Ventures. The VC currently invests in sustainability-focused startups that are predominantly based in the Netherlands and north-western Europe. It currently has 27 portfolio companies including fair coffee brand Wakuli and cultured meat pioneer Masa Meat. The “Rubicon crossing” VC has just raised €110m for its second impact fund, Rubio Fund 2, in October 2021.Recent investments include participation in the $43m Series B round of food-sharing app OLIO in September 2021 and the €3.6m seed round in July 2021 for Portuguese Arborea that uses micro-organisms in biotech for foodtech applications.
COO and Co-founder of Impress
Diliara Lupenko is the COO and co-founder of Impress, an invisible aligners company regarded as one of the fastest-growing telemedicine startups in Europe. Prior to Impress, Lupenko served for over eight years as COO and CFO of Aquaton, a bathroom furniture plant and a subsidiary of the ROCA Group. She also worked in the Transaction Service Group in KPMG, managing financial due diligence of over 100 targets, pre-sale preparation of vendors, and restructuring, amongst other tasks. Impress is not Lupenko’s first entrepreneurial experience. In 2013 she co-founded Style Me Up the first Russian marketplace for designers of jewelry and accessories.
Diliara Lupenko is the COO and co-founder of Impress, an invisible aligners company regarded as one of the fastest-growing telemedicine startups in Europe. Prior to Impress, Lupenko served for over eight years as COO and CFO of Aquaton, a bathroom furniture plant and a subsidiary of the ROCA Group. She also worked in the Transaction Service Group in KPMG, managing financial due diligence of over 100 targets, pre-sale preparation of vendors, and restructuring, amongst other tasks. Impress is not Lupenko’s first entrepreneurial experience. In 2013 she co-founded Style Me Up the first Russian marketplace for designers of jewelry and accessories.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Roger Federer, the Swiss 20-times Grand Slam tennis champion, has turned into an angel investor while planning his professional life beyond and after his tennis sports career.In 2019, he invested in On, the Swiss running shoe manufacturer for an undisclosed funding amount. Federer currently has no formal role in the company but he’s actively involved in its R&D and product development. “I feel like I can give input on any of the lines, the shoes, anything moving forward. I can give my opinion on anything and On can either take it or leave it. I feel like [with] a major brand like Nike, that's literally impossible. It just wouldn't work,” he has said.More recently, Federer participated in a Series D funding round backing the first Chilean unicorn NotCo, which sells plant-based food and beverage products across Latin America and the US.
Roger Federer, the Swiss 20-times Grand Slam tennis champion, has turned into an angel investor while planning his professional life beyond and after his tennis sports career.In 2019, he invested in On, the Swiss running shoe manufacturer for an undisclosed funding amount. Federer currently has no formal role in the company but he’s actively involved in its R&D and product development. “I feel like I can give input on any of the lines, the shoes, anything moving forward. I can give my opinion on anything and On can either take it or leave it. I feel like [with] a major brand like Nike, that's literally impossible. It just wouldn't work,” he has said.More recently, Federer participated in a Series D funding round backing the first Chilean unicorn NotCo, which sells plant-based food and beverage products across Latin America and the US.
Co-founder and Data Scientist of Plant on Demand
Ulises Vidal Sanz graduated in 2016 with a bachelor’s in Telecommunications Engineering from the University of Granada in Spain. In 2015, he also spent a year studying in Finland at Tampere University of Technology. On his return, Vidal completed a master’s in Data Science at MBIT School in Madrid in 2018.He worked as a data scientist at online marketing agency OrbitalAds. In 2018, he co-founded Plant on Demand (POD) with university friends. In 2019, he started working full-time as a data scientist and full-stack developer at POD to help small-scale farmers get the best market prices by selling their produce directly to local residents.
Ulises Vidal Sanz graduated in 2016 with a bachelor’s in Telecommunications Engineering from the University of Granada in Spain. In 2015, he also spent a year studying in Finland at Tampere University of Technology. On his return, Vidal completed a master’s in Data Science at MBIT School in Madrid in 2018.He worked as a data scientist at online marketing agency OrbitalAds. In 2018, he co-founded Plant on Demand (POD) with university friends. In 2019, he started working full-time as a data scientist and full-stack developer at POD to help small-scale farmers get the best market prices by selling their produce directly to local residents.
The GlassWall Syndicate is a US investment group comprising venture capitalists, foundations, trusts, non-profits and individual investors. The VC members include Blue Horizon, Veg Invest and New Crop Capital.The syndicate funds are mostly invested in foodtech companies like Mosa Meat and Beyond Meat that are currently disrupting the traditional global food industry.
The GlassWall Syndicate is a US investment group comprising venture capitalists, foundations, trusts, non-profits and individual investors. The VC members include Blue Horizon, Veg Invest and New Crop Capital.The syndicate funds are mostly invested in foodtech companies like Mosa Meat and Beyond Meat that are currently disrupting the traditional global food industry.
COO and co-founder of Plant on Demand
Santiago Corral Rodriguez worked at Dutch online lighting supplier Any Amp as a video manager and country manager in Spain from 2013 to 2015. He also worked at Dutch produce distributor Direct Fresh International in administration and control assistance in 2016.After completing a business administration degree at Granada University in 2012, Corral went to Finland to study International Business at SeAMK (Seinäjoki University of Applied Sciences) and graduated in 2016. He also obtained a postgrad qualification in Entrepreneurship at University of Deusto in the Basque Country, Spain.He worked at Sonar Ventures in 2017 before co-founding Plant on Demand (POD) in 2018 as COO and Customer Success Manager. POD is an e-marketplace and online management platform for small-scale food producers.
Santiago Corral Rodriguez worked at Dutch online lighting supplier Any Amp as a video manager and country manager in Spain from 2013 to 2015. He also worked at Dutch produce distributor Direct Fresh International in administration and control assistance in 2016.After completing a business administration degree at Granada University in 2012, Corral went to Finland to study International Business at SeAMK (Seinäjoki University of Applied Sciences) and graduated in 2016. He also obtained a postgrad qualification in Entrepreneurship at University of Deusto in the Basque Country, Spain.He worked at Sonar Ventures in 2017 before co-founding Plant on Demand (POD) in 2018 as COO and Customer Success Manager. POD is an e-marketplace and online management platform for small-scale food producers.
Co-founder, COO of Cocuus
Daniel Rico Aldaz is the Spanish COO and co-founder at 3D printing food tech and cell-based meat startup Cocuus, where he has worked since he co-founded it in 2017. Before Cocuus, Rico founded an industrial design company, Rico Ingenio, which was established in 2009, where he continues to be a founding partner.His last full-time position before Cocuus was at systems automation company Kaizen for less than a year, where he headed up the technical office. Prior to that, Rico briefly led the computer-to-plate (CTP) and quality control departments at printers Estellaprint. For 15 years, until 2016, Rico was founder at his own industrial design company El Seis Y El Cuatro.Rico’s varied career has also seen him as head designer of children's parks and gyms at Mader Play, as an IT teacher at a worker’s foundation and as both a graphic and an artistic designer in two communication agencies and a lighting company. During his career, Rico has had experience with design and manufacturing in 3D processes, which he used to innovate in Cocuus. Rico did not attend university. He studied music and design at high school.
Daniel Rico Aldaz is the Spanish COO and co-founder at 3D printing food tech and cell-based meat startup Cocuus, where he has worked since he co-founded it in 2017. Before Cocuus, Rico founded an industrial design company, Rico Ingenio, which was established in 2009, where he continues to be a founding partner.His last full-time position before Cocuus was at systems automation company Kaizen for less than a year, where he headed up the technical office. Prior to that, Rico briefly led the computer-to-plate (CTP) and quality control departments at printers Estellaprint. For 15 years, until 2016, Rico was founder at his own industrial design company El Seis Y El Cuatro.Rico’s varied career has also seen him as head designer of children's parks and gyms at Mader Play, as an IT teacher at a worker’s foundation and as both a graphic and an artistic designer in two communication agencies and a lighting company. During his career, Rico has had experience with design and manufacturing in 3D processes, which he used to innovate in Cocuus. Rico did not attend university. He studied music and design at high school.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Irish alt-protein foodtech Plantruption produces nutritious fish substitutes without artificial additives, leveraging the health benefits of sustainably sourced local seaweed.
Irish alt-protein foodtech Plantruption produces nutritious fish substitutes without artificial additives, leveraging the health benefits of sustainably sourced local seaweed.
Grain Meat: Focusing on whole cut plant-based meat
With its proprietary fiber weaving technique and specially-designed machinery, Wuxi-based Grain Meat aims to replicate the texture and even the grain of real meat
Zhenmeat: Offering a modern plant-based meat alternative in China
The Chinese startup is providing a product adapted for Chinese tastes in an emerging market.
Plant-based meat faces backlash in China despite gaining traction
An innocuous video clip sparked debate on social media over plant-based meat, with suspicion about its nutritional value, cost-effectiveness and even the motives of foreign companies
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
Indonesia's Green Rebel Foods to take its Asian-inspired plant-based meat regional
F&B veteran duo behind the Burgreens spinoff plans Series A fundraising by end-2021 for manufacturing and regional expansion
In a nascent market, one-year-old Starfield has brought its offerings to around 3,000 F&B outlets and generated RMB 10m in revenue
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
Yali Bio: Recreating a juicy steak in plant-based alternatives
Founded by the former head of Impossible Foods’ pilot plant, this Bay Area genomics and foodtech startup is one of the first to engineer a better fat for plant-based meat
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Novameat: 3D printing tech to develop meat substitute products
Italian scientist Giuseppe Scionti has repurposed bioprinting technology used to create an artificial human ear to develop a plant-based "steak"
China a “positive environment” for uptake of cultured meat, researcher tells Future Food Asia
But for interested cultured meat companies, China-based Chloe Dempsey suggests it would be better to wait, observe and learn more about the market before trying to tap its massive potential
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
NotCo: Will this Bezos-backed plant-based foodtech be Chile's first unicorn?
Armed with $85m Series C funding, NotCo has expanded to the US, competing head-on with popular US alt-protein brands for a foothold in the multibillion-dollar vegan market
Sorry, we couldn’t find any matches for “Plant-based meat”.
